Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Post-chemotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07613359
What this trial is testing

Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney Transplant

Who this might be right for
Antibody-Mediated Rejection (AMR)
Takeda 36
Not applicableActive Not RecruitingNCT07032220
What this trial is testing

Application of Targeted Axillary Lymph Node Resection in Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: an Open-label, Multicenter Study

Who this might be right for
Breast Cancer SurgeryNeoadjuvant TherapySentinel Lymph Node Biopsy (SLNB)
Fujian Medical University Union Hospital 175
Post-approval studies (Phase 4)WithdrawnNCT00706173
What this trial is testing

Trial of Hydrocortisone for Post-Traumatic Stress Disorder (PTSD)

Who this might be right for
Post-traumatic Stress Disorder
University of California, San Diego
Testing effectiveness (Phase 2)Study completedNCT02047474
What this trial is testing

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Who this might be right for
Acinar Cell Adenocarcinoma of the PancreasDuct Cell Adenocarcinoma of the PancreasStage I Pancreatic Cancer+2 more
Yale University 46
Large-scale testing (Phase 3)Study completedNCT01168973
What this trial is testing

Chemotherapy and Ramucirumab Versus Chemotherapy Alone in Second Line Non-Small Cell Lung Cancer (NSCLC) Participants Who Received Prior First Line Platinum-based Chemotherapy

Who this might be right for
Non-Small Cell Lung Cancer
Eli Lilly and Company 1,253
Not applicableLooking for participantsNCT01617382
What this trial is testing

Register With Patients in Which Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) Was Performed

Who this might be right for
Peritoneal CarcinomatosisPseudomyxoma PeritoneiPeritoneal Mesothelioma
Universitaire Ziekenhuizen KU Leuven 125
Testing effectiveness (Phase 2)Study completedNCT00410696
What this trial is testing

Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy

Who this might be right for
Hematological NeoplasmsTumors
Armando Santoro, MD 80
Very early researchEnded earlyNCT03515941
What this trial is testing

Postoperative Chemoradiation or Chemotherapy After Preoperative Chemotherapy for Gastric Cancers

Who this might be right for
Gastrointestinal Cancer
Tannaz Armaghany 6
Large-scale testing (Phase 3)Ended earlyNCT01420679
What this trial is testing

Pralatrexate vs Observation Following CHOP-based Chemotherapy in Undiagnosed Peripheral T-cell Lymphoma Patients

Who this might be right for
Peripheral T-cell Lymphoma
Spectrum Pharmaceuticals, Inc 21
Testing effectiveness (Phase 2)UnknownNCT00795613
What this trial is testing

Positron Emission Tomography (PET)-Adapted Chemotherapy In Advanced Hodgkin Lymphoma (HL)

Who this might be right for
HODGKIN LYMPHOMA
Ospedale Santa Croce-Carle Cuneo 450
Testing effectiveness (Phase 2)Study completedNCT02077569
What this trial is testing

AKT Inhibitor in Oestrogen Positive Breast Cancer

Who this might be right for
Invasive Breast Cancer
University of Nottingham 48
Very early researchStudy completedNCT03426969
What this trial is testing

Combination Chemotherapy, Total Body Irradiation, and Donor Blood Stem Cell Transplant in Treating Patients With Primary or Secondary Myelofibrosis

Who this might be right for
Primary MyelofibrosisSecondary Myelofibrosis
M.D. Anderson Cancer Center 3
Large-scale testing (Phase 3)Study completedNCT02324088
What this trial is testing

Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer

Who this might be right for
Inflammatory Breast Cancer
UNICANCER 174
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06063070
What this trial is testing

First-line Maintenance Treatment With Fluzoparib Plus Bevacizumab in Advanced BRCA Wild Type Ovarian Cancer

Who this might be right for
Ovarian CancerHigh Grade Serous Adenocarcinoma of OvaryHigh Grade Endometrioid Ovarian Cancer+2 more
Sun Yat-sen University 44
Testing effectiveness (Phase 2)Looking for participantsNCT06272214
What this trial is testing

Adjuvant Radiotherapy for Esophageal Squamous Cell Carcinoma in the Era of Immunotherapy

Who this might be right for
Adjuvant Radiotherapy
Zhejiang Cancer Hospital 146
Testing effectiveness (Phase 2)Ended earlyNCT01972516
What this trial is testing

Tivozanib As Maintenance Therapy In GYN

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Dana-Farber Cancer Institute 4
Testing effectiveness (Phase 2)Study completedNCT00340184
What this trial is testing

A Safety and Efficacy of CCRT With Paclitaxel/Carboplatin as Adjuvant Therapy to Post-operative Cervical Cancer Patients

Who this might be right for
Cervical Cancer
Korean Gynecologic Oncology Group 55
Testing effectiveness (Phase 2)Study completedNCT03906058
What this trial is testing

Anlotinib in Recurrent or Metastatic Nasopharyngeal Carcinoma Patients After Failure of no Less Than Second-line Therapy

Who this might be right for
Nasopharyngeal Carcinoma
Sun Yat-sen University 39
Large-scale testing (Phase 3)UnknownNCT03693248
What this trial is testing

Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal Cancer

Who this might be right for
Ovarian Cancer Stage IIICOvarian Cancer Stage IVFallopian Tube Cancer+1 more
Seoul National University Hospital 298
Not applicableLooking for participantsNCT06626243
What this trial is testing

Analysis of RATS, VATS and Open Lung Resections After Neoadjuvant Chemo-immunotherapy in Patients Performed in Five Referred Centers

Who this might be right for
Non-Small Cell Lung Cancer
Scientific Institute San Raffaele 140
Next Page